Fireside Chat, Interview, Panel
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2023
- Rapid advancements in medicines, vaccines, diagnostics, care delivery models, and AI are projected to boost lifespans and quality of life globally across all communities and continents.
- Dr. Califf anticipates the loss of 460,000 Americans this year from tobacco-related illness, driven by nicotine addiction among millions of teenagers through vaping.
- Policy expectations include eventual government action based on evidence regarding ultra-processed foods and dietary supplements, provided low-cost studies are conducted to inform decision-making.
- The NIH portfolio is expected to shift to direct academic medical centers toward clinical studies that significantly impact health outcomes, pending the confirmation of the new director.
- CMS is expected to implement grand-scale measures to encourage clinician participation in research, potentially utilizing AI and virtual methodologies to reach populations with limited access to clinics.
- A strategy shift is predicted for combating misinformation, moving away from single press releases toward building personal, trusted networks that share voice and interact directly with the public.
- The FDA is expected to improve communication by using plain English or Spanish rather than technical language, while non-government entities are expected to increase efforts in promoting factual information.
- AI and virtual tools are expected to rapidly free clinical personnel from administrative burdens like billing and charting, thereby restoring focus to physician-patient interaction.
- Regulatory frameworks for generative AI are expected to involve complex, extensive discussions due to the intricacy of the technology.
- AI algorithms are expected to degrade within a year if deployed without constant monitoring and tuning to track relevant data within a living health system, necessitating ongoing validation.